EFPIA warns law threatens flu vax timelines; Failure to vaccinate migrants undermining immunization program;

> A European trade group has warned a new law may affect seasonal vaccine production timelines. Article

> Failure to vaccinate migrants and refugees is undermining Australia's immunization program. Item

> The partnering of Clarkson University and the Trudeau Institute has created new vaccine research opportunities. Feature

> Australian authorities are investigating alleged irregularities in an anti-vaccine group's financial statements. News

> The WHO is holding a series of events to train countries in vaccine adverse event communication strategies. Program

> GeoVax Labs has published data from preclinical tests of its HIV vaccine. Release

> Arecor is presenting stability data for its vaccine formulation technology. Post

Suggested Articles

GSK's Shingrix has generated blockbuster sales early in the launch, but there's a lot of remaining opportunity, an exec said at JPM.

Quickly after Merck's world-first Ebola vaccine approval in Europe, U.S. authorities licensed the shot.

In an effort to stop an Ebola outbreak that has claimed 2,200 lives at the Rwanda border, J&J is shipping 200,000 doses of its vaccine to the country.